| 摘要 |
<p>The invention concerns a pharmaceutical composition in the form of a gastric resident matrix tablet, comprising an active principle, characterized in that when contacted with an environment representing a gastric fluid, it increases after fifteen minutes in volume, by a swelling rate of at least 200 %.</p> |
